Bitmain
Seed–Series B
What they invest in
from 2 of 2 portfolio companiesAI & Machine Learning ×1Crypto & Web3 ×1Developer Tools ×1Enterprise Software ×1Fintech ×1Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathCboe Clear U.S. is a CFTC-registered derivatives clearinghouse that provides clearing infrastructure for digital asset derivatives and event contracts. It acts as a central counterparty for trades, managing counterparty risk through margin collection, collateral management, and settlement services.
Crypto & Web3FintechChicago, US
Simplex provides automated provider enrollment management for healthcare networks, handling CAQH profile setup, payer applications, and compliance tracking across multiple states and insurers. The platform uses AI agents to submit applications, monitor status, fix corrections, and deliver final enrollment determinations with full audit trails.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareHealthtechSan Francisco, US
Frequently asked questions
- What stage does Bitmain invest at?
- Bitmain invests at the Seed, Series A, Series B stages.
- What sectors does Bitmain focus on?
- Bitmain focuses on Crypto & Web3.
Images
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
83North is a lean venture capital partnership of four equal general partners that has operated for 19 years. The firm invests globally across the US, Europe, and Israel, and in 2025 raised what it describes as its final fund, shifting focus toward selectively pursuing new opportunities while supporting existing portfolio companies.
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.